Jalal Moludi, Amir Saber, Morteza Arab Zozani, Shima Moradi, Yasaman Azamian, Salimeh Hajiahmadi, Yahya Pasdar, Fardin Moradi
{"title":"The Efficacy of Probiotics Supplementation on the Quality of Life of Patients with Gastrointestinal Disease: A Systematic Review of Clinical Studies.","authors":"Jalal Moludi, Amir Saber, Morteza Arab Zozani, Shima Moradi, Yasaman Azamian, Salimeh Hajiahmadi, Yahya Pasdar, Fardin Moradi","doi":"10.3746/pnf.2024.29.3.237","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with gastrointestinal (GI) disorders might benefit from probiotic supplementation to resolve their bowel symptoms and enhance their quality of life (QoL). This systematic review aimed to evaluate the effects of oral probiotic supplementation on improving QoL. Relevant studies were systematically searched in online databases, including PubMed, Scopus, Embase, ProQuest, and Google Scholar up to September 2022 using relevant keywords. Studies that were conducted on GI patients and presented QoL outcomes were included. The Revised Cochrane Risk of Bias 2 tool and the Risk Of Bias In Non-randomized Studies of Intervention tool were used to assess the risk of bias. Of the 4,555 results found in the systematic search of databases, only 36 studies were eligible for evaluation. According to this systematic review, 24 studies reported improvements, whereas 12 studies reported no improvements on QoL in GI patients supplemented with probiotics. We found that probiotics may improve the QoL of patients with GI diseases and related metabolic complications. Therefore, probiotics can be a useful supportive treatment strategy in these patients.</p>","PeriodicalId":20424,"journal":{"name":"Preventive Nutrition and Food Science","volume":"29 3","pages":"237-255"},"PeriodicalIF":1.6000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450280/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventive Nutrition and Food Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3746/pnf.2024.29.3.237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Patients with gastrointestinal (GI) disorders might benefit from probiotic supplementation to resolve their bowel symptoms and enhance their quality of life (QoL). This systematic review aimed to evaluate the effects of oral probiotic supplementation on improving QoL. Relevant studies were systematically searched in online databases, including PubMed, Scopus, Embase, ProQuest, and Google Scholar up to September 2022 using relevant keywords. Studies that were conducted on GI patients and presented QoL outcomes were included. The Revised Cochrane Risk of Bias 2 tool and the Risk Of Bias In Non-randomized Studies of Intervention tool were used to assess the risk of bias. Of the 4,555 results found in the systematic search of databases, only 36 studies were eligible for evaluation. According to this systematic review, 24 studies reported improvements, whereas 12 studies reported no improvements on QoL in GI patients supplemented with probiotics. We found that probiotics may improve the QoL of patients with GI diseases and related metabolic complications. Therefore, probiotics can be a useful supportive treatment strategy in these patients.
胃肠道(GI)疾病患者可通过补充益生菌来缓解肠道症状并提高生活质量(QoL)。本系统综述旨在评估口服益生菌补充剂对改善 QoL 的影响。截至 2022 年 9 月,我们使用相关关键词在 PubMed、Scopus、Embase、ProQuest 和 Google Scholar 等在线数据库中对相关研究进行了系统检索。纳入的研究对象为消化道疾病患者,并提供了 QoL 结果。评估偏倚风险时使用了修订版 Cochrane Risk of Bias 2 工具和 Risk Of Bias In Non-randomized Studies of Intervention 工具。在对数据库进行系统检索后发现的 4,555 项结果中,只有 36 项研究符合评估条件。根据该系统性综述,有 24 项研究报告称,补充益生菌的消化道疾病患者的 QoL 有改善,而有 12 项研究报告称 QoL 没有改善。我们发现,益生菌可改善消化道疾病及相关代谢并发症患者的 QoL。因此,益生菌对这些患者来说是一种有用的辅助治疗策略。